Someone asked “Doctors, what were the wildest self-diagnoses a patient was actually right about?” and people shared their ...

A novel scoring system can effectively stratify patients with autoimmune inflammatory rheumatic diseases into high- and low-risk groups for serious infections after high-dose glucocorticoid therapy.

A new global survey suggests pet owners may recognize parasite risks but still need more guidance on prevention. In a March 18 press release, Boehringer Ingelheim said 43% of the ...

Officials with the FDA have approved a label expansion for fluralaner for extended-release injectable suspension (Bravecto ...

Annexon (NASDAQ:ANNX) used its Investor Day presentation to outline the scientific rationale and clinical progress for ...

Promising Phase 2a data announced for izicopan, underscoring its potential as a meaningfully differentiated, effective and safe oral inhibitor of ...